Hanmi Science headquarters in Seoul (Courtesy of News1) La Defense Partners is expected to exercise a casting vote over the ongoing management dispute at Hanmi Science Co. after the Seoul-based private equity firm increased its stake in the holding company of Hanmi Pharmaceutical Co. to 5%.In a
National Pension Fund's headquarters in Jeonju, North Jeolla Province South Korea’s National Pension Service is indicating more active involvement in the management of Hanmi Pharmaceutical Group embroiled in a years-long family feud over management control after changing the purpose of it
Hanmi Pharmaceutical headquarters in Seoul (File photo) South Korean Hanmi Pharmaceutical Group’s founding family is set to conclude an ongoing feud as the group’s top individual shareholder has agreed to cooperate with the eldest son, who had been embroiled in a dispute with his mo
Hanmi Chairwoman and Hanmi Science co-CEO Song Young-sook (Courtesy of Yonhap) South Korea’s Hanmi Pharmaceutical Group is set to enter a new chapter of an ongoing family feud less than two months after the founding family’s two sons’ triumphant return to the group as one of t
Hanmi Pharmaceutical Group’s proposed merger with OCI Holdings Co. has collapsed after two sons of the group’s founding family, who opposed the merger, won a vote battle against the merger's proponents on Thursday.At the annual general meeting (AGM) of Hanmi Science Co., the holdin
Lim Jong-yoon, the eldest son of Hanmi Pharmaceutical Group's late founder Lim Sung-ki (Courtesy of Hanmi) Hanmi Pharmaceutical Group’s aim to merge with chemicals giant OCI Group is hitting some roadblocks amid a prolonged feud between the family owners of Hanmi, one of the top drugmaker
Hanmi Pharmaceutical Group headquarters in Seoul (Courtesy of Hanmi) South Korea’s top proxy advisory firm has recommended that shareholders of Hanmi Science Co. vote in favor of Hanmi Pharmaceutical Group’s late founder's two sons in their bid to return as board members of the grou